Bifidobacterium lactis HN019
Bifidobacterium animalis subsp. lactis HN019 is among the more extensively studied probiotic strains, with human clinical trials exploring its potential across several areas. Randomized controlled trials have examined it in the context of gut regularity, including a 2024 RCT examining functional constipation symptoms, and preliminary human data have also examined oral health markers such as gingivitis. Animal and in vitro work has examined interactions with the immune system and gut microbiota composition, and the mechanisms and clinical relevance remain under investigation. Human evidence exists but is still building, and no single benefit has been established. These are research topics, not findings; the papers do not establish that this strain treats or prevents any condition.
Where it's been studied Tags come from a conservative keyword scan of each paper's title, abstract, and summary. A tag is research coverage, not measured effect. How we classify this →
Share of this strain's 188 body-system-tagged papers that concern each system. Research coverage, not measured effect.
+4 more systems
Symptoms in the research A tag means the paper's text names the symptom or condition — research coverage, not evidence of benefit. How we classify this →
Share of this strain's 116 symptom-tagged papers that mention each symptom or condition. Research coverage, not evidence of benefit.
Research Study-type filters use AI-classified labels, audited but not guaranteed — check the paper itself before leaning on one. How we classify this →
237 papers reference this strain in the probiotic database.
Discussion
Be the first to comment.
Sign in to join the discussion.
Citations
Selected papers that name this strain.
-
[1]
PMID 40320938 →Effect of an 8‐Week Bifidobacterium lactis HN019 Supplementation on Functional Constipation: A Multi‐Center, Triple‐Blind, Randomized, Placebo‐Controlled Trial· Molecular Nutrition & Food Research · 2025
-
[2]
Source →Effectiveness of Oral Microbiome-Targeted Probiotics in Reducing Systemic Inflammation and Periodontal Disease Progression· Indus journal of bioscience research. · 2025
-
[3]
Source →Susceptibilidade ao desenvolvimento da doença periodontal experimental na prole de camundongos com histórico de suplementação probiótica pré-natal e perinatal· · 2024
-
[4]
PMID 39356506 →Eight-Week Supplementation With Bifidobacterium lactis HN019 and Functional Constipation· JAMA Network Open · 2024
-
[5]
PMID 37630731 →The Effect of Delivery Matrix on Bifidobacterium animalis subsp. lactis HN019 Survival through In Vitro Human Digestion· Nutrients · 2023
-
[6]
PMID 36004715 →Comparison of two probiotics in follow-on formula: Bifidobacterium animalis subsp. lactis HN019 reduced upper respiratory tract infections in Chinese infants· Beneficial Microbes · 2022
-
[7]
PMID 36305963 →Effects of oral administration of Bifidobacterium animalis subsp. lactis HN019 on the treatment of plaque-induced generalized gingivitis· Clinical Oral Investigations · 2022
-
[8]
Source →Table_1_Bifidobacterium animalis subsp. lactis HN019 Effects on Gut Health: A Review.docx· Figshare · 2021
-
[9]
PMID 32960889 →Bifidobacterium animalis subsp lactis HN019 presents antimicrobial potential against periodontopathogens and modulates the immunological response of oral mucosa in periodontitis patients· PLoS ONE · 2020
-
[10]
Source →Screening of Bifidobacterium strains to bind with Benzo[a]pyrene under food stress factors and the mechanism of the process· Journal of Food Processing and Preservation · 2019